Owners, management and financials
CVR: 42425990
Previous names: Rodes ApS
DKK 3,592,336
Gross profit
Net result: DKK 1,503,450
Jens Bo Rode Hansen (50-66,65%), Gitte Rode (50-66,65%)
CVR · view owners
Jens Bo Rode Hansen
Board: 1 member
CVR · view management
Active
Founded 28 May 2021
CVR · view overview
1 employee
CVR · 2026
Name registered: Rodes Biopharma ApS
CVR · 19/10/2026
View the full event history
Rodes Biopharma ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2021. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named Rodes ApS. The management consists of Jens Bo Rode Hansen. The board consists of Gitte Rode. The company is owned by Jens Bo Rode Hansen and Gitte Rode. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 3,592,336 and a net result of DKK 1,503,450 compared with DKK 93,839 the year before. Equity in the 2025 report amounted to DKK 1,863,111.
Source: annual report 2025, Danish Business Authority
Rodes ApS demonstrates a strong upward trajectory in profitability and gross profit margins since its inception in 2021. In 2025, the company reported a gross profit of 3,592,336 DKK and a profit of 1,503,450 DKK, marking significant growth from 1,139,251 DKK in gross profit and 93,839 DKK in profit in 2024. The equity position has also improved notably, rising to 1,863,111 DKK in 2025 from 494,661 DKK in 2024, indicating a solid foundation for future growth. While revenue figures are not disclosed, the consistent increase in gross profit suggests effective management and operational efficiency within the consulting industry. Overall, Rodes ApS is well-positioned for continued success, although the lack of revenue data may raise concerns regarding transparency and market reach.
AI-generated summary · Generated 16/08/2026
konsulent
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 3.6M | 1.5M | 2.5M | 1.9M | 2 | |
| 202401/01/2024 – 31/12/2024 | 1.1M | 94K | 1.5M | 495K | 2 | |
| 202301/01/2023 – 31/12/2023 | 1.8M | 387K | 1.5M | 523K | 1 | |
| 202201/01/2022 – 31/12/2022 | 487K | 390K | 1M | 483K | 1 |
Compared to 11.524 companies in Virksomhedsrådgivning og anden ledelsesrådgivning
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorThe CVR number of Rodes Biopharma ApS is 42425990.
Rodes Biopharma ApS is owned by Jens Bo Rode Hansen and Gitte Rode.
The management of Rodes Biopharma ApS consists of Jens Bo Rode Hansen.
The board of Rodes Biopharma ApS consists of Gitte Rode.
In 2025, Rodes Biopharma ApS reported a gross profit of DKK 3,592,336.
Rodes Biopharma ApS had 1 employee in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new phone: 28340871, new email: [email protected] (October 19, 2026).
On October 19, 2026, the company changed its name from Rodes ApS to Rodes Biopharma ApS.
Rodes Biopharma ApS has published its annual report for 2025. Gross profit came to DKK 3,592,336, and the net result was DKK 1,503,450.
Rodes Biopharma ApS has published its annual report for 2024. Gross profit came to DKK 1,139,251, and the net result was DKK 93,839.
Rodes Biopharma ApS has published its annual report for 2023. Gross profit came to DKK 1,773,764, and the net result was DKK 386,985.
Rodes Biopharma ApS has published its annual report for 2022. Gross profit came to DKK 486,825, and the net result was DKK 389,813.
Rodes Biopharma ApS has published its interim report for the period June 1, 2021 to December 31, 2021.
As of April 26, 2022, Jens Bo Rode Hansen is registered as an owner of Rodes Biopharma ApS with an ownership share of 50%.
As of April 26, 2022, Gitte Rode is registered as an owner of Rodes Biopharma ApS with an ownership share of 50%.
As of February 28, 2022, Gitte Rode has joined the board of directors of Rodes Biopharma ApS.
As of June 1, 2021, Jens Bo Rode Hansen is registered as adm. dir. of Rodes Biopharma ApS.
Rodes Biopharma ApS was founded on May 28, 2021.
Companies in the same industry and area
CVR 43237179
CVR 25998189
CVR 36151609
CVR 24237893
CVR 27114482
